“Extending QAD to SteriPack USA enables us to rapidly
onboard new operations that can run at peak performance to deliver
consistent supply to our medical device customers.”

“QAD Enterprise Applications offer SteriPack USA business process
continuity across all of our facilities,” said Tony Paolino, president,
SteriPack USA. “Extending QAD to SteriPack USA enables us to rapidly
onboard new operations that can run at peak performance to deliver
consistent supply to our medical device customers.”

QAD Offers the Power of Process Continuity to Global Life Science
Customers

QAD Enterprise Applications provide powerful end-to-end capabilities
that improve business performance across a global enterprise. Available
in multiple languages with true multi-tiered on-premise QAD On Demand
software as a service (SaaS) and hybrid deployment options, QAD supports
the needs of global life science companies like SteriPack to deliver to
consistent quality and comply with regulatory requirements regardless of
deployment options.

QAD Enterprise Applications support critical quality requirements,
including regulatory compliance, CAPA, and Device History/Electronic
Batch Record requirements. QAD solutions can be simply validated to
comply with Current Good Manufacturing Practices (cGMP). QAD provides
capabilities and tools to enable SteriPack services to deliver the very
highest levels of quality at all times. QAD offers enhanced controls and
audit capabilities, along with eSignature support to help meet the
mandate of compliance tracking.

End-to-End Multi-site Capabilities for Plant Locations and Financials

Designed for single- or multi-site operations, QAD Enterprise
Applications accommodate different production models, plant locations
and financial structures for global manufacturing companies in more than
90 countries, 27 languages and in multiple currencies.

“Today’s manufacturing companies, like SteriPack, need enterprise
solutions that provide the utmost agility for the rapidly shifting
global marketplace,” said Steve Gardner, EMEA vice president, sales and
marketing, QAD. “QAD Enterprise Applications and QAD On Demand give
medical device manufacturers a flexible, cost-effective global ERP
solution to help them bring their products to market on time, while
meeting regulatory requirements and managing risk.”

SteriPack is a leading global supplier of cleanroom sterilized packaging
solutions for the Medical Device Industry offering a one stop solution
for Medical Device companies looking to have their products assembled,
packaged, sterilized and tested. For more information, please visit http://www.SteriPackgroup.com/.

About QAD

QAD is a leading provider of enterprise applications for global
manufacturing companies specializing in automotive, consumer products,
electronics, food and beverage, industrial and life sciences products.
QAD applications provide critical functionality for managing
manufacturing resources and operations within and beyond the enterprise,
enabling global manufacturers to collaborate with their customers,
suppliers and partners to make and deliver the right product, at the
right cost and at the right time.

For more information about QAD, telephone +1 805-566-6000, or visit the
QAD web site at www.qad.com.

“QAD” is a registered trademark of QAD Inc. All other products or
company names herein may be trademarks of their respective owners.

Note to Investors: This press release contains certain forward-looking
statements made under the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. Words such as “expects,”
“believes,” “anticipates,” “could,” “will likely result,” “estimates,”
“intends,” “may,” “projects,” “should,” and variations of these words
and similar expressions are intended to identify these forward looking
statements. Forward-looking statements are based on the company’s
current expectations and assumptions regarding its business, the economy
and future conditions. A number of risks and uncertainties could cause
actual results to differ materially from those in the forward-looking
statements. These risks include, but are not limited to, evolving demand
for the company's software products and products that operate with the
company's products; the company's ability to sustain license and service
demand; the company's ability to leverage changes in technology; the
company's ability to sustain customer renewal rates at current levels;
the publication of opinions by industry and financial analysts about the
company, its products and technology; the reliability of estimates of
transaction and integration costs and benefits; the entry of new
competitors or new offerings by existing competitors and the associated
announcement of new products and technological advances by them; delays
in localizing the company's products for new or existing markets; the
ability to recruit and retain key personnel; delays in sales as a result
of lengthy sales cycles; changes in operating expenses, pricing, timing
of new product releases, the method of product distribution or product
mix; timely and effective integration of newly acquired businesses;
general economic conditions; exchange rate fluctuations; and, the global
political environment. In addition, revenue and earnings in the
enterprise resource planning (ERP) software industry are subject to
fluctuations. Software license revenue, in particular, is subject to
variability with a significant proportion of revenue earned in the last
month of each quarter. Given the high margins associated with license
revenue, modest fluctuations can have a substantial impact on net
income. Investors should not use any one quarter's results as a
benchmark for future performance. For a more detailed description of the
risk factors associated with the company and the industries in which it
operates, please refer to the company's Annual Report on Form 10-K for
fiscal 2012 ended January 31, 2012, and in particular, the section
entitled “Risk Factors” therein, and in other periodic reports the
company files with the Securities and Exchange Commission.